Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-28

Clinical Trial Update: Selegiline in Treatment of Cocaine Dependence - 2 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating selegiline for cocaine use disorder has completed; the update notes the study status but does not include outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selegiline (selegiline)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED